ATAI Life Sciences NV
F:9VC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ATAI Life Sciences NV
F:9VC
|
DE |
|
S
|
SciBase Holding AB (publ)
F:5J3
|
SE |
|
Vinci SA
PAR:DG
|
FR |
|
L
|
Lam Research Corp
F:LAR
|
US |
|
U
|
UniCredit SpA
XMUN:CRIN
|
IT |
Wall St Price Targets
9VC Price Targets Summary
ATAI Life Sciences NV
According to Wall Street analysts, the average 1-year price target for
9VC is 10.76 EUR with a low forecast of 5.33 EUR and a high forecast of 19.78 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9VC's stock price target?
Price Target
10.76
EUR
According to Wall Street analysts, the average 1-year price target for
9VC is 10.76 EUR with a low forecast of 5.33 EUR and a high forecast of 19.78 EUR.
What is the Revenue forecast for ATAI Life Sciences NV?
Projected CAGR
-30%
The compound annual growth rate for Revenue over the next 3 years is -30%.